Molecular docking showed that the binding energy of Linebacker for ACE2 was higher compared to chloroquine which is currently being investigated in clinical trials as a possible prophylactic and therapeutic in the treatment of COVID-19. This evidence concerns the gene ACE2 and COVID-19.